Crinetics Pharmaceuticals, Inc. (CRNX)

Crinetics Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	3,591	2,377	985	1,349	465	608
Market Cap Growth	276.29%	141.36%	-27.03%	190.50%	-23.56%	-15.69%
Enterprise Value	2,742	1,869	652	1,018	297	494
PE Ratio	-	-11.08	-6.01	-12.54	-6.29	-12.05
PS Ratio	1819.28	592.26	207.88	1251.83	6542.73	509.42
PB Ratio	4.10	4.41	3.11	4.07	2.75	5.19
P/FCF Ratio	-17.66	-13.90	-8.43	-15.16	-7.47	-12.97
P/OCF Ratio	-18.26	-14.29	-8.55	-15.23	-7.49	-13.10
EV/Sales Ratio	1388.81	465.63	137.66	944.66	4185.47	413.83
EV/EBITDA Ratio	-10.37	-8.80	-4.01	-9.57	-4.09	-10.01
EV/EBIT Ratio	-10.23	-8.71	-3.98	-9.46	-4.03	-9.79
EV/FCF Ratio	-13.06	-10.93	-5.58	-11.44	-4.78	-10.53
Debt / Equity Ratio	0.06	0.10	0.01	0.01	0.02	0.04
Debt / EBITDA Ratio	-0.23	-0.24	-0.02	-0.03	-0.06	-0.10
Debt / FCF Ratio	-0.28	-0.30	-0.03	-0.03	-0.06	-0.10
Quick Ratio	17.43	12.74	12.11	20.89	16.34	14.26
Current Ratio	17.72	13.07	12.45	21.55	16.92	14.79
Asset Turnover	0.00	0.01	0.01	0.01	0	0.01
Return on Equity (ROE)	-42.50%	-52.90%	-48.30%	-49.10%	-44.20%	-37.30%
Return on Assets (ROA)	-37.00%	-45.50%	-43.90%	-45.80%	-40.70%	-33.90%
Return on Capital (ROIC)	-26.76%	-37.68%	-52.56%	-32.15%	-43.34%	-44.13%
Earnings Yield	-6.56%	-9.03%	-16.65%	-7.98%	-15.89%	-8.30%
FCF Yield	-5.14%	-7.19%	-11.87%	-6.60%	-13.39%	-7.71%
Buyback Yield / Dilution	-34.10%	-11.71%	-35.24%	-26.23%	-25.95%	-99.10%
Total Shareholder Return	-34.10%	-11.71%	-35.24%	-26.23%	-25.95%	-99.10%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).